• Health Catalyst Invests In healthfinch

    To kick off the third quarter, Health Catalyst has announced its second acquisition of 2020. On July 9, the company announced it acquired healthfinch, Inc. for roughly $40 million. healthfinch provides a workflow integration engine delivering insights and analytics into EMR workflows to automate physicians’ ability to close patient care gaps in... Read More »
  • Second Quarter Healthcare M&A Activity Drops

    The decline in second quarter healthcare M&A probably won’t surprise many of our readers. The second quarter was the first full quarter of healthcare M&A in the shadow of the COVID-19 pandemic, and deal making took a hit as a result, as shown in results from our DSO database. Compared with Q1:20, Q2:20 dropped 20%, with 322 transactions... Read More »
  • Sanofi Inks New Licensing Deal

    Just weeks following its agreement with Translate Bio (NASDAQ: TBIO) for COVID-19 vaccine development, Sanofi (NYSE: SNY) has a new agreement with Kymera Therapeutics Inc. Sanofi and Kymera are signing a multi-program collaboration to develop and commercialize first-in-class protein degrader therapies targeting IRAK4 in patients with... Read More »
  • Summit BHC Expands Into West Virginia

    Private equity-backed Summit BHC has announced a new acquisition in West Virginia. The behavioral health treatment company added Highland Hospital to its network for an undisclosed sum. Meridian Behavioral Health Systems, LLC is selling Highland Hospital, an inpatient psychiatric facility (131 beds) with 24 beds dedicated to psychiatric... Read More »
  • Health Care M&A Deals, July 10, 2020

    The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week based on... Read More »
Novartis Enters the Game With Ubisoft

Novartis Enters the Game With Ubisoft

Last week, an unusual partnership in the health care M&A space hit the headlines. Novartis AG (NYSE: NVS), the global pharmaceutical company, bought Amblyotech, Inc., a software startup that, in collaboration with Ubisoft (OTCMKTS: UBSFF) and McGill University, is developing digital technology for the treatment of amblyopia (lazy eye), a leading cause of vision loss. Ubisoft is a major player in the video game industry and not a company we expected to be treading in the health care market. It owns several development studios worldwide and publishes multiple major video game franchises. Amblyotech uses active gaming and passive video technology with 3-D glasses, training the eyes to... Read More »
PE-Backed Coronis Health Acquires RCM Provider

PE-Backed Coronis Health Acquires RCM Provider

In the eHealth sector, acquisitions for revenue cycle management (RCM) firms are usually headline-worthy deals, such as Frazier Healthcare Partners’ $250 million purchase of MedData, Inc. from Mednax (NYSE: MD) back in October 2019. RCM companies tend to service hospitals, large health systems and healthcare providers. MedData, for instance, serves more than 10,000 physicians in a network of more than 3,000 facilities nationwide. However, Coronis Health focuses on something more niche. A portfolio company of 424 Capital (formerly known as Brook Venture Partners), Coronis Health announced last week it acquired Reliabill, LLC, an RCM provider to the behavioral health market, focusing... Read More »
PE-Backed Coronis Health Acquires RCM Provider

DXC Technology Divests State & Local HHS Business

When Mike Salvino took over as CEO of DXC Technology (NYSE: DXC) in September 2019, he announced during his first earnings call that the company was planning strategic alternatives, including the possible divesture of three of its non-core assets, which made up roughly 25% of the company’s revenue. One of those segments included its U.S. state and local health and human services business (HHS business), which DXC managed to divest last week to Veritas Capital Management LLC for $5 billion in cash. DXC’s HHS business is an end-to-end provider of technology solutions critical to the administration and operations of health programs. The business facilitates performance... Read More »
NaviHealth Deal Focuses on Seniors

NaviHealth Deal Focuses on Seniors

It’s been a few years, four to be exact, since NaviHealth announced an acquisition. The silence was broken in late February, when it acquired Innovative Healthcare Delivery (IHD). The deal is part of NaviHealth’s mission to extend non-clinical services into seniors homes. Financial terms were not disclosed. IHD, based in Henderson, Nevada, specializes in identifying and addressing social determinants of health to improve quality of life and clinical outcomes for patients. It delivers a high-touch, patient-centric and non-clinical approach that is paired with proprietary workflow and patient engagement technology to address barriers and improve efficiences to get the right care... Read More »

Citadel Group Goes International

The Citadel Group Limited (ASX: CGL), an Australia-based business services company, announced this month it was acquiring Wellbeing Software for roughly $134 million, or 6.2x the group’s 2019 revenue of $21.6 million. Elysian Capital is selling the eHealth firm, which provides radiology and maternity software that manage patient workflow and data, as well as electronic health record management and data management solutions. The company’s platform, which includes Healthcare Software Systems, Euroking and Apollo Medical Systems, is used by more than 80% of NHS organizations. This merger will support Wellbeing Software’s international market expansion and compliment... Read More »
Hot Healthcare Sectors for Investment, Growth & Consolidation in 2020

Hot Healthcare Sectors for Investment, Growth & Consolidation in 2020

Every year, starting in November, the crystal balls come out and the prognostications begin. What will the new year bring? Who or what will make out better and who or what will not? We talked with Gary Herschman, a member of Epstein Becker Green’s Healthcare and Life Sciences practice, about the healthcare sectors he and his firm are watching in 2020. Here are their predictions for 2020. Health Care M&A: What do you see as the biggest themes in the healthcare industry this year? There are a lot of moving parts, from the discovery of new drugs to the shifting attention to post-acute care. Gary Herschman: We see three key “drivers” of health industry transformation that are already... Read More »